Bavituximab (PGN-401)
Revision as of 14:40, 26 April 2023 by Warner-admin (talk | contribs) (Text replacement - "2 PubMed]" to "2/ PubMed]")
Mechanism of action
Binds to phosphatidylserine, provoking an immune response.
Preliminary data
Non-small cell lung cancer
- Digumarti R, Bapsy PP, Suresh AV, Bhattacharyya GS, Dasappa L, Shan JS, Gerber DE. Bavituximab plus paclitaxel and carboplatin for the treatment of advanced non-small-cell lung cancer. Lung Cancer. 2014 Nov;86(2):231-6. Epub 2014 Aug 24. link to original article PubMed
Also known as
- Code name: PGN401
- Brand name: Tarvacin